Aptevo Therapeutics Correlations

APVO Stock  USD 2.57  0.10  4.05%   
The current 90-days correlation between Aptevo Therapeutics and Cyclerion Therapeutics is 0.06 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptevo Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptevo Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Aptevo Therapeutics Correlation With Market

Average diversification

The correlation between Aptevo Therapeutics and DJI is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aptevo Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptevo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Aptevo Stock, please use our How to Invest in Aptevo Therapeutics guide.

Moving together with Aptevo Stock

  0.74CDIOW Cardio DiagnosticsPairCorr
  0.68ELVN Enliven TherapeuticsPairCorr
  0.81SCLX Scilex HoldingPairCorr
  0.92ASMB Assembly Biosciences Earnings Call This WeekPairCorr
  0.81CMND Clearmind Medicine CommonPairCorr
  0.66CRNX Crinetics PharmaceuticalsPairCorr
  0.72CAT CaterpillarPairCorr
  0.64HD Home DepotPairCorr
  0.71DIS Walt DisneyPairCorr
  0.82MSFT MicrosoftPairCorr

Moving against Aptevo Stock

  0.84LUCD Lucid DiagnosticsPairCorr
  0.8WM Waste ManagementPairCorr
  0.61PG Procter GamblePairCorr
  0.57GE GE AerospacePairCorr
  0.34PLX Protalix BiotherapeuticsPairCorr
  0.91JNJ Johnson JohnsonPairCorr
  0.88T ATT Inc Earnings Call TomorrowPairCorr
  0.69IBM International BusinessPairCorr
  0.61XOM Exxon Mobil CorpPairCorr
  0.6CVX Chevron CorpPairCorr
  0.59INTC IntelPairCorr
  0.57MMM 3M CompanyPairCorr
  0.5CSCO Cisco SystemsPairCorr
  0.37DD Dupont De NemoursPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
LGVNQNRX
QNRXLRMR
RNXTLRMR
RNXTQNRX
NTRBACHL
RNXTCYCN
  
High negative correlations   
QNRXNTRB
ACHLLRMR
QNRXACHL
RNXTACHL
LGVNNTRB
LGVNACHL

Risk-Adjusted Indicators

There is a big difference between Aptevo Stock performing well and Aptevo Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aptevo Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Aptevo Therapeutics Corporate Executives

Elected by the shareholders, the Aptevo Therapeutics' board of directors comprises two types of representatives: Aptevo Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aptevo. The board's role is to monitor Aptevo Therapeutics' management team and ensure that shareholders' interests are well served. Aptevo Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aptevo Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.